IP Library Assignment 063038/0951
Patent Assignment
Reel/Frame 063038/0951

Change of Name

Recorded: 2023-03-10 Pages: 4
Assignor
SILVERBACK THERAPEUTICS, INC.
Executed: 2022-11-07
Assignee
ARS PHARMACEUTICALS, INC.
11682 EL CAMINO REAL, SUITE 120, SAN DIEGO, CALIFORNIA, 92130
Covered Properties (5)
Nectin-4 Antibody Conjugates and Uses Thereof
Application: 17/180,110 →
Publication: US 2021/0275683
Nectin-4 Antibody Conjugates and Uses Thereof
Application: 17/493,266 →
Publication: US 2022/0105196
Nectin-4 Antibody Conjugates and Uses Thereof
Application: 62/979,755 →
Nectin-4 Antibody Conjugates and Uses Thereof
Application: 63/047,124 →
Nectin-4 Antibody Conjugates and Uses Thereof
Application: 63/092,714 →
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 22, 2020
From: BAUM, PETER; DUBOSE, ROBERT; ODEGARD, VALERIE; STEVENS, BRENDA
To: SILVERBACK THERAPEUTICS
Reel/Frame 053004/0125 →
Assignment of Assignor's Interest Aug 28, 2020
From: BAUM, PETER; DUBOSE, ROBERT; ODEGARD, VALERIE; STEVENS, BRENDA
To: SILVERBACK THERAPEUTICS
Reel/Frame 053626/0289 →
Assignment of Assignor's Interest Nov 30, 2020
From: BAUM, PETER R.; DUBOSE, ROBERT; ODEGARD, VALERIE; STEVENS, BRENDA
To: SILVERBACK THERAPEUTICS, INC.
Reel/Frame 054495/0128 →
Assignment of Assignor's Interest Feb 17, 2021
From: BAUM, PETER; DUBOSE, ROBERT; ODEGARD, VALERIE; STEVENS, BRENDA
To: SILVERBACK THERAPEUTICS, INC.
Reel/Frame 055294/0750 →
Assignment of Assignor's Interest Feb 17, 2021
From: BAUM, PETER; DUBOSE, ROBERT; ODEGARD, VALERIE; STEVENS, BRENDA
To: SILVERBACK THERAPEUTICS, INC.
Reel/Frame 055294/0619 →
Assignment of Assignor's Interest Jun 22, 2021
From: BAUM, PETER R.; DUBOSE, ROBERT; ODEGARD, VALERIE; STEVENS, BRENDA
To: SILVERBACK THERAPEUTICS, INC.
Reel/Frame 056617/0761 →
Assignment of Assignor's Interest Mar 6, 2023
From: BAUM, PETER R.; DUBOSE, ROBERT; ODEGARD, VALERIE; STEVENS, BRENDA
To: SILVERBACK THERAPEUTICS, INC.
Reel/Frame 062895/0873 →
Assignment of Assignor's Interest Apr 21, 2023
From: ARS PHARMACEUTICALS, INC.
To: ARARIS BIOTECH AG
Reel/Frame 063397/0878 →